NTRK2 and neuroblastoma: Here we analyzed the interplay between extracellular vesicles from preclinical neuroblastoma models with differential expression of the master regulators, NTRK1 and NTRK2, and CAR T cells, in order to identify molecular factors that can be investigated and maybe even manipulated to improve response to CAR T cell therapy.